Tag: Tarveda Therapeutics

October 24, 2019 Off

Tarveda Therapeutics preclinical studies of treatment for certain lung cancer shows PEN-221 allows deep tumor penetration

By BusinessWire

Tarveda Therapeutics said in a PR Friday that PEN-221 miniature drug conjugate allow for deep tumor penetration, while limiting plasma…

March 26, 2019 Off

Tarveda Therapeutics to Present Nonclinical Data on PEN-221 in Combination with Epigenetic Modulation at the 2019 AACR Annual Meeting

By BusinessWire

– Data demonstrate how an HDAC inhibitor increases the tumor expression of SSTR2 with synergy of efficacy – WATERTOWN, Mass.–(BUSINESS…